![Gregory Burshtein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 303 312 $ al 31/07/2026
Gregory Burshtein has been working at Entera Bio Ltd. since 2012 and holds the position of Chief Research & Development Officer starting in 2024.
Dr. Burshtein completed undergraduate, graduate, and doctorate degrees at The Hebrew University of Jerusalem.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ENTERA BIO LTD. 0,06 % | 07/08/2026 | 101.442 ( 0,06 % ) | 303 312 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENTERA BIO LTD. | Director Técnico/Científico/I+D | 01/05/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entera Bio Ltd.
 Entera Bio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures flu medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
